Detalhe da pesquisa
1.
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease.
Clin Microbiol Rev
; : e0007423, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38602408
2.
Race and ethnicity: Risk factors for fungal infections?
PLoS Pathog
; 19(1): e1011025, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602962
3.
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management.
Clin Microbiol Rev
; 36(3): e0001923, 2023 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439685
4.
Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis.
Antimicrob Agents Chemother
; 68(5): e0158423, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38526046
5.
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.
Lancet
; 401(10370): 49-59, 2023 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442484
6.
The dog as a sentinel and animal model for coccidioidomycosis.
Med Mycol
; 62(1)2024 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38148116
7.
Comparison of coccidioidal complement fixation and quantitative immunodiffusion serology at a reference laboratory.
Med Mycol
; 62(1)2024 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061838
8.
Glucocorticoids as a risk factor for infection and adverse outcomes in non-HIV and non-transplant patients with cryptococcal meningitis.
Mycoses
; 67(3): e13709, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429225
9.
Isavuconazole in the Treatment of Chronic Forms of Coccidioidomycosis.
Clin Infect Dis
; 76(12): 2196-2199, 2023 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905151
10.
Multicentric Case Series and Literature Review of Coccidioidal Otomastoiditis.
Emerg Infect Dis
; 29(7): 1297-1301, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37347877
11.
Treatment pathways, switches, and inappropriate treatment during invasive pulmonary aspergillosis: real-world experiences from a global research network study.
Antimicrob Agents Chemother
; 67(10): e0072123, 2023 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671871
12.
Review of Clinical and Laboratory Diagnostics for Coccidioidomycosis.
J Clin Microbiol
; 61(5): e0158122, 2023 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883820
13.
Endemic mycoses - are we making progress in management?
Curr Opin Infect Dis
; 36(6): 436-442, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37755392
14.
Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial.
J Antimicrob Chemother
; 78(10): 2471-2480, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596890
15.
Invasive pulmonary aspergillosis real-world outcomes: Clinical features and risk factors associated with increased mortality.
Med Mycol
; 61(8)2023 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491703
16.
Diabetes Mellitus Type 2 as a Risk Factor and Outcome Modifier for Cryptococcosis in HIV Negative, Non-transplant Patients, a Propensity Score Match Analysis.
Curr Microbiol
; 80(12): 396, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37907808
17.
Secondary invasive fungal infection in hospitalised patients with COVID-19 in the United States.
Mycoses
; 66(6): 527-539, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36808656
18.
Treatment of Fusarium Infection of the Central Nervous System: A Review of Past Cases to Guide Therapy for the Ongoing 2023 Outbreak in the United States and Mexico.
Mycopathologia
; 188(6): 973-981, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37653167
19.
Controversies in the Management of Central Nervous System Coccidioidomycosis.
Clin Infect Dis
; 75(4): 555-559, 2022 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717645
20.
New Perspectives on Antimicrobial Agents: Isavuconazole.
Antimicrob Agents Chemother
; 66(9): e0017722, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35969068